Autori: Zhang Jingshan
| Naslov | Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 (Article) |
| Autori | Goel Shom Tan Antoinette R Rugo Hope S Aftimos Philippe Andric Zoran G  Beelen Andrew Paul Zhang Jingshan Yi John S Malik Rajesh K O'Shaughnessy Joyce
|
| Info | FUTURE ONCOLOGY, (2022), vol. 18 br. 33, str. 3701-3711 |
| Projekat | G1 Therapeutics; Eli Lilly; Merck; Pfizer; AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi; Gilead; Lilly; Macrogenics; Novartis; OBI; Odonate; Polyphor; Roche; Seattle Genetics; Sermonix |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
